Integrated Diagnostics Holdings plc (LON: IDHC)

Market Cap	208.07M
Revenue (ttm)	78.23M
Net Income (ttm)	13.46M
Shares Out	581.33M
EPS (ttm)	0.02
PE Ratio	15.87
Forward PE	16.48
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,872
Open	0.431
Previous Close	0.450
Day's Range	0.431 - 0.449
52-Week Range	0.275 - 0.540
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 3, 2025

About LON: IDHC

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, including positron emission tomography – computed tomography (PET-CT), magnetic resonance imaging (MRI), computed tomography (CT), mammography, ultrasound, x-ray, electromyog...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1979
• Employees: 6,692
• Stock Exchange: London Stock Exchange
• Ticker Symbol: IDHC

Financial Performance

In 2023, IDHC's revenue was 4.12 billion, an increase of 14.35% compared to the previous year's 3.61 billion. Earnings were 510.30 million, a decrease of -5.69%.

Financial numbers in EGP